XML 27 R71.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Details) (USD $)
In Millions, except Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Stock options, shares        
Cash received from stock option exercises     $ 12.6 $ 14.5
Stock-based compensation costs        
Stock-based compensation expense 2.9 2.6 8.0 7.3
Income tax benefit (1.1) (1.0) (3.0) (2.7)
Stock-based compensation expense, net of income taxes 1.8 1.6 5.0 4.6
Excess tax benefit from stock-based compensation 14.6 7.1 30.0 25.7
Stock Options
       
Stock options, shares        
Outstanding at the beginning of the period (in shares)     1,215,083  
Granted (in shares)     130,670  
Exercised (in shares)     (484,788)  
Forfeited (in shares)     (6,762)  
Outstanding at the end of the period (in shares) 854,203   854,203  
Exercisable balance at the end of the period (in shares) 558,920   558,920  
Cash received from stock option exercises     12.6  
Stock option activity, additional disclosure        
Outstanding at the beginning of the period, Weighted-Average Exercise Price (in dollars per share)     $ 53.95  
Granted, Weighted-Average Exercise Price (in dollars per share)     $ 207.11  
Exercised, Weighted-Average Exercise Price (in dollars per share)     $ 26.29  
Forfeited, Weighted-Average Exercise Price (in dollars per share)     $ 112.29  
Outstanding at the end of the period, Weighted-Average Exercise Price (in dollars per share) $ 92.62   $ 92.62  
Exercisable balance at the end of the period, Weighted-Average Exercise Price (in dollars per share) $ 59.52   $ 59.52  
Stock-based compensation costs        
Pre-tax unrecognized compensation cost, net of estimated forfeitures 15.6   15.6  
Weighted-average period over which expense will be recognized     2 years 3 months 18 days  
Aggregate Intrinsic Value        
Balance at the beginning of the period, Aggregate Intrinsic Value     111.4  
Exercised     79.9  
Balance at the end of the period, Aggregate Intrinsic Value 110.7   110.7  
Exercisable balance at the end of the period, Aggregate Intrinsic Value 90.9   90.9  
Restricted Stock
       
Restricted stock, shares        
Balance at the beginning of the period (in shares)     112,571  
Granted (in shares)     25,662  
Vested (in shares)     (37,779)  
Balance at the end of the period (in shares) 100,454   100,454  
Restricted stock activity, additional disclosure        
Outstanding at the beginning of the period, Weighted-Average Grant Date Fair Value (in dollars per share)     $ 100.83  
Granted, Weighted-Average Grant Date Fair Value (in dollars per share)     $ 201.22  
Vested, Weighted-Average Grant Date Fair Value (in dollars per share)     $ 95.35  
Outstanding at the end of the period, Weighted-Average Grant Date Fair Value (in dollars per share) $ 128.54   $ 128.54  
Stock-based compensation costs        
Pre-tax unrecognized compensation cost, net of estimated forfeitures 7.3   7.3  
Weighted-average period over which expense will be recognized     2 years 1 month 6 days  
Phantom units | TNCLP
       
Stock-based compensation costs        
Stock-based compensation expense $ 0.2   $ 0.8